nodes	percent_of_prediction	percent_of_DWPC	metapath
Zuclopenthixol—HTR2A—phrenic nerve—germ cell cancer	0.0402	0.0843	CbGeAlD
Zuclopenthixol—HTR2A—choroid plexus—germ cell cancer	0.029	0.061	CbGeAlD
Zuclopenthixol—DRD1—telencephalic ventricle—germ cell cancer	0.0218	0.0458	CbGeAlD
Zuclopenthixol—HTR2A—myenteric nerve plexus—germ cell cancer	0.0206	0.0432	CbGeAlD
Zuclopenthixol—HTR6—ganglion—germ cell cancer	0.0183	0.0384	CbGeAlD
Zuclopenthixol—DRD5—ganglion—germ cell cancer	0.0178	0.0373	CbGeAlD
Zuclopenthixol—HTR2A—trigeminal nerve—germ cell cancer	0.0147	0.0308	CbGeAlD
Zuclopenthixol—HTR2A—vagus nerve—germ cell cancer	0.0137	0.0288	CbGeAlD
Zuclopenthixol—DRD1—ganglion—germ cell cancer	0.0136	0.0285	CbGeAlD
Zuclopenthixol—DRD2—telencephalic ventricle—germ cell cancer	0.0129	0.0271	CbGeAlD
Zuclopenthixol—HTR2A—cranial nerve—germ cell cancer	0.0105	0.022	CbGeAlD
Zuclopenthixol—HTR2A—pons—germ cell cancer	0.0103	0.0217	CbGeAlD
Zuclopenthixol—HTR2A—telencephalic ventricle—germ cell cancer	0.00851	0.0179	CbGeAlD
Zuclopenthixol—DRD2—ganglion—germ cell cancer	0.00803	0.0169	CbGeAlD
Zuclopenthixol—HTR2A—urine—germ cell cancer	0.00777	0.0163	CbGeAlD
Zuclopenthixol—HTR2A—appendage—germ cell cancer	0.00756	0.0159	CbGeAlD
Zuclopenthixol—HTR2A—pineal body—germ cell cancer	0.00738	0.0155	CbGeAlD
Zuclopenthixol—CYP2D6—urine—germ cell cancer	0.00708	0.0149	CbGeAlD
Zuclopenthixol—HTR6—telencephalon—germ cell cancer	0.00705	0.0148	CbGeAlD
Zuclopenthixol—DRD5—telencephalon—germ cell cancer	0.00686	0.0144	CbGeAlD
Zuclopenthixol—DRD1—brainstem—germ cell cancer	0.00591	0.0124	CbGeAlD
Zuclopenthixol—HTR2A—ganglion—germ cell cancer	0.00529	0.0111	CbGeAlD
Zuclopenthixol—DRD1—telencephalon—germ cell cancer	0.00524	0.011	CbGeAlD
Zuclopenthixol—DRD5—female gonad—germ cell cancer	0.00465	0.00977	CbGeAlD
Zuclopenthixol—HTR2A—endothelium—germ cell cancer	0.00457	0.00959	CbGeAlD
Zuclopenthixol—HTR6—head—germ cell cancer	0.00439	0.00921	CbGeAlD
Zuclopenthixol—DRD5—endocrine gland—germ cell cancer	0.00433	0.00909	CbGeAlD
Zuclopenthixol—DRD5—head—germ cell cancer	0.00427	0.00897	CbGeAlD
Zuclopenthixol—HTR2A—blood vessel—germ cell cancer	0.00421	0.00884	CbGeAlD
Zuclopenthixol—DRD1—midbrain—germ cell cancer	0.00376	0.0079	CbGeAlD
Zuclopenthixol—ADRA1A—brainstem—germ cell cancer	0.00356	0.00747	CbGeAlD
Zuclopenthixol—DRD2—brainstem—germ cell cancer	0.00349	0.00733	CbGeAlD
Zuclopenthixol—DRD2—eye—germ cell cancer	0.0034	0.00713	CbGeAlD
Zuclopenthixol—DRD2—retina—germ cell cancer	0.00337	0.00707	CbGeAlD
Zuclopenthixol—DRD1—head—germ cell cancer	0.00326	0.00685	CbGeAlD
Zuclopenthixol—HTR6—brain—germ cell cancer	0.00318	0.00668	CbGeAlD
Zuclopenthixol—ADRA1A—telencephalon—germ cell cancer	0.00316	0.00663	CbGeAlD
Zuclopenthixol—HRH1—trigeminal ganglion—germ cell cancer	0.00311	0.00654	CbGeAlD
Zuclopenthixol—DRD2—telencephalon—germ cell cancer	0.0031	0.0065	CbGeAlD
Zuclopenthixol—DRD5—brain—germ cell cancer	0.0031	0.0065	CbGeAlD
Zuclopenthixol—ADRA2A—trigeminal ganglion—germ cell cancer	0.00306	0.00642	CbGeAlD
Zuclopenthixol—HTR2A—neck—germ cell cancer	0.00301	0.00632	CbGeAlD
Zuclopenthixol—HRH1—eye—germ cell cancer	0.00268	0.00563	CbGeAlD
Zuclopenthixol—DRD2—pituitary gland—germ cell cancer	0.00252	0.00529	CbGeAlD
Zuclopenthixol—HTR2A—embryo—germ cell cancer	0.00251	0.00527	CbGeAlD
Zuclopenthixol—HRH1—telencephalon—germ cell cancer	0.00245	0.00513	CbGeAlD
Zuclopenthixol—ADRA2A—telencephalon—germ cell cancer	0.0024	0.00504	CbGeAlD
Zuclopenthixol—DRD1—brain—germ cell cancer	0.00237	0.00497	CbGeAlD
Zuclopenthixol—HRH1—decidua—germ cell cancer	0.00232	0.00487	CbGeAlD
Zuclopenthixol—HTR2A—brainstem—germ cell cancer	0.0023	0.00483	CbGeAlD
Zuclopenthixol—ADRA1A—adrenal gland—germ cell cancer	0.0023	0.00483	CbGeAlD
Zuclopenthixol—ADRA2A—decidua—germ cell cancer	0.00228	0.00478	CbGeAlD
Zuclopenthixol—HTR2A—eye—germ cell cancer	0.00224	0.0047	CbGeAlD
Zuclopenthixol—DRD2—midbrain—germ cell cancer	0.00222	0.00467	CbGeAlD
Zuclopenthixol—HTR2A—retina—germ cell cancer	0.00222	0.00466	CbGeAlD
Zuclopenthixol—CYP2D6—brainstem—germ cell cancer	0.0021	0.0044	CbGeAlD
Zuclopenthixol—HTR2A—telencephalon—germ cell cancer	0.00204	0.00429	CbGeAlD
Zuclopenthixol—ADRA2A—gonad—germ cell cancer	0.002	0.00421	CbGeAlD
Zuclopenthixol—ADRA1A—endocrine gland—germ cell cancer	0.00199	0.00418	CbGeAlD
Zuclopenthixol—ADRA2A—uterus—germ cell cancer	0.00199	0.00418	CbGeAlD
Zuclopenthixol—ADRA1A—head—germ cell cancer	0.00197	0.00413	CbGeAlD
Zuclopenthixol—ADRA2A—pituitary gland—germ cell cancer	0.00196	0.00411	CbGeAlD
Zuclopenthixol—DRD2—endocrine gland—germ cell cancer	0.00195	0.0041	CbGeAlD
Zuclopenthixol—DRD2—head—germ cell cancer	0.00193	0.00405	CbGeAlD
Zuclopenthixol—ADRA2A—medulla oblongata—germ cell cancer	0.00189	0.00396	CbGeAlD
Zuclopenthixol—DRD2—testis—germ cell cancer	0.00186	0.00391	CbGeAlD
Zuclopenthixol—CYP2D6—telencephalon—germ cell cancer	0.00186	0.00391	CbGeAlD
Zuclopenthixol—HRH1—adrenal gland—germ cell cancer	0.00178	0.00374	CbGeAlD
Zuclopenthixol—ADRA1A—cerebellum—germ cell cancer	0.00176	0.00369	CbGeAlD
Zuclopenthixol—ADRA2A—adrenal gland—germ cell cancer	0.00175	0.00367	CbGeAlD
Zuclopenthixol—Malaise—Dactinomycin—germ cell cancer	0.00175	0.00333	CcSEcCtD
Zuclopenthixol—Decreased appetite—Vinblastine—germ cell cancer	0.00174	0.00333	CcSEcCtD
Zuclopenthixol—Urine output increased—Methotrexate—germ cell cancer	0.00174	0.00331	CcSEcCtD
Zuclopenthixol—Urinary tract disorder—Cisplatin—germ cell cancer	0.00173	0.00331	CcSEcCtD
Zuclopenthixol—Leukopenia—Dactinomycin—germ cell cancer	0.00173	0.00331	CcSEcCtD
Zuclopenthixol—Connective tissue disorder—Cisplatin—germ cell cancer	0.00173	0.0033	CcSEcCtD
Zuclopenthixol—ADRA2A—midbrain—germ cell cancer	0.00173	0.00362	CbGeAlD
Zuclopenthixol—Urethral disorder—Cisplatin—germ cell cancer	0.00172	0.00329	CcSEcCtD
Zuclopenthixol—DRD2—cerebellum—germ cell cancer	0.00172	0.00361	CbGeAlD
Zuclopenthixol—Gynaecomastia—Methotrexate—germ cell cancer	0.00172	0.00328	CcSEcCtD
Zuclopenthixol—Pain—Vinblastine—germ cell cancer	0.00172	0.00327	CcSEcCtD
Zuclopenthixol—Constipation—Vinblastine—germ cell cancer	0.00172	0.00327	CcSEcCtD
Zuclopenthixol—HTR2A—gonad—germ cell cancer	0.0017	0.00358	CbGeAlD
Zuclopenthixol—Hepatobiliary disease—Etoposide—germ cell cancer	0.0017	0.00324	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Bleomycin—germ cell cancer	0.00169	0.00323	CcSEcCtD
Zuclopenthixol—Visual impairment—Cisplatin—germ cell cancer	0.00169	0.00323	CcSEcCtD
Zuclopenthixol—ADRA2A—spinal cord—germ cell cancer	0.00168	0.00353	CbGeAlD
Zuclopenthixol—Agranulocytosis—Etoposide—germ cell cancer	0.00167	0.00319	CcSEcCtD
Zuclopenthixol—Vision blurred—Ifosfamide—germ cell cancer	0.00167	0.00319	CcSEcCtD
Zuclopenthixol—HTR2A—pituitary gland—germ cell cancer	0.00166	0.00349	CbGeAlD
Zuclopenthixol—HRH1—female gonad—germ cell cancer	0.00166	0.00348	CbGeAlD
Zuclopenthixol—Thrombocytopenia—Bleomycin—germ cell cancer	0.00166	0.00317	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Vinblastine—germ cell cancer	0.00165	0.00316	CcSEcCtD
Zuclopenthixol—Myalgia—Dactinomycin—germ cell cancer	0.00165	0.00315	CcSEcCtD
Zuclopenthixol—Ill-defined disorder—Ifosfamide—germ cell cancer	0.00165	0.00314	CcSEcCtD
Zuclopenthixol—Eye disorder—Cisplatin—germ cell cancer	0.00164	0.00313	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Vinblastine—germ cell cancer	0.00164	0.00313	CcSEcCtD
Zuclopenthixol—Tinnitus—Cisplatin—germ cell cancer	0.00164	0.00313	CcSEcCtD
Zuclopenthixol—Cardiac disorder—Cisplatin—germ cell cancer	0.00163	0.00311	CcSEcCtD
Zuclopenthixol—Agitation—Ifosfamide—germ cell cancer	0.00163	0.00311	CcSEcCtD
Zuclopenthixol—ADRA2A—female gonad—germ cell cancer	0.00163	0.00342	CbGeAlD
Zuclopenthixol—Discomfort—Dactinomycin—germ cell cancer	0.00163	0.00311	CcSEcCtD
Zuclopenthixol—Anorexia—Bleomycin—germ cell cancer	0.00161	0.00308	CcSEcCtD
Zuclopenthixol—HTR2A—medulla oblongata—germ cell cancer	0.0016	0.00337	CbGeAlD
Zuclopenthixol—Malaise—Ifosfamide—germ cell cancer	0.0016	0.00305	CcSEcCtD
Zuclopenthixol—Vertigo—Ifosfamide—germ cell cancer	0.00159	0.00304	CcSEcCtD
Zuclopenthixol—Urinary tract disorder—Etoposide—germ cell cancer	0.00159	0.00303	CcSEcCtD
Zuclopenthixol—Leukopenia—Ifosfamide—germ cell cancer	0.00159	0.00303	CcSEcCtD
Zuclopenthixol—Polyuria—Methotrexate—germ cell cancer	0.00159	0.00303	CcSEcCtD
Zuclopenthixol—Immune system disorder—Cisplatin—germ cell cancer	0.00159	0.00303	CcSEcCtD
Zuclopenthixol—Abdominal pain—Vinblastine—germ cell cancer	0.00159	0.00303	CcSEcCtD
Zuclopenthixol—Hypotension—Bleomycin—germ cell cancer	0.00158	0.00302	CcSEcCtD
Zuclopenthixol—Urethral disorder—Etoposide—germ cell cancer	0.00158	0.00301	CcSEcCtD
Zuclopenthixol—Arrhythmia—Cisplatin—germ cell cancer	0.00157	0.003	CcSEcCtD
Zuclopenthixol—Palpitations—Ifosfamide—germ cell cancer	0.00157	0.00299	CcSEcCtD
Zuclopenthixol—Thrombocytopenia—Dactinomycin—germ cell cancer	0.00155	0.00295	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.00154	0.00295	CcSEcCtD
Zuclopenthixol—HRH1—endocrine gland—germ cell cancer	0.00154	0.00324	CbGeAlD
Zuclopenthixol—Convulsion—Ifosfamide—germ cell cancer	0.00154	0.00293	CcSEcCtD
Zuclopenthixol—Hypertension—Ifosfamide—germ cell cancer	0.00153	0.00292	CcSEcCtD
Zuclopenthixol—Malnutrition—Cisplatin—germ cell cancer	0.00153	0.00292	CcSEcCtD
Zuclopenthixol—Erythema—Cisplatin—germ cell cancer	0.00153	0.00292	CcSEcCtD
Zuclopenthixol—HRH1—head—germ cell cancer	0.00152	0.0032	CbGeAlD
Zuclopenthixol—Paraesthesia—Bleomycin—germ cell cancer	0.00152	0.0029	CcSEcCtD
Zuclopenthixol—ADRA2A—endocrine gland—germ cell cancer	0.00152	0.00318	CbGeAlD
Zuclopenthixol—Dyspnoea—Bleomycin—germ cell cancer	0.00151	0.00288	CcSEcCtD
Zuclopenthixol—Myalgia—Ifosfamide—germ cell cancer	0.00151	0.00288	CcSEcCtD
Zuclopenthixol—Flatulence—Cisplatin—germ cell cancer	0.00151	0.00288	CcSEcCtD
Zuclopenthixol—Anorexia—Dactinomycin—germ cell cancer	0.00151	0.00288	CcSEcCtD
Zuclopenthixol—Eye disorder—Etoposide—germ cell cancer	0.0015	0.00287	CcSEcCtD
Zuclopenthixol—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.0015	0.00286	CcSEcCtD
Zuclopenthixol—ADRA2A—head—germ cell cancer	0.0015	0.00314	CbGeAlD
Zuclopenthixol—Cardiac disorder—Etoposide—germ cell cancer	0.00149	0.00285	CcSEcCtD
Zuclopenthixol—Discomfort—Ifosfamide—germ cell cancer	0.00149	0.00285	CcSEcCtD
Zuclopenthixol—HTR2A—adrenal gland—germ cell cancer	0.00149	0.00312	CbGeAlD
Zuclopenthixol—Hypersensitivity—Vinblastine—germ cell cancer	0.00148	0.00282	CcSEcCtD
Zuclopenthixol—Decreased appetite—Bleomycin—germ cell cancer	0.00147	0.00281	CcSEcCtD
Zuclopenthixol—HRH1—testis—germ cell cancer	0.00147	0.00309	CbGeAlD
Zuclopenthixol—HTR2A—midbrain—germ cell cancer	0.00147	0.00308	CbGeAlD
Zuclopenthixol—Angiopathy—Etoposide—germ cell cancer	0.00146	0.00279	CcSEcCtD
Zuclopenthixol—Immune system disorder—Etoposide—germ cell cancer	0.00145	0.00278	CcSEcCtD
Zuclopenthixol—Pain—Bleomycin—germ cell cancer	0.00145	0.00277	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Ifosfamide—germ cell cancer	0.00145	0.00276	CcSEcCtD
Zuclopenthixol—ADRA2A—testis—germ cell cancer	0.00145	0.00303	CbGeAlD
Zuclopenthixol—Vision blurred—Cisplatin—germ cell cancer	0.00144	0.00275	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.00144	0.00275	CcSEcCtD
Zuclopenthixol—Asthenia—Vinblastine—germ cell cancer	0.00144	0.00275	CcSEcCtD
Zuclopenthixol—Tremor—Cisplatin—germ cell cancer	0.00143	0.00274	CcSEcCtD
Zuclopenthixol—HTR2A—spinal cord—germ cell cancer	0.00143	0.003	CbGeAlD
Zuclopenthixol—ADRA1A—brain—germ cell cancer	0.00143	0.00299	CbGeAlD
Zuclopenthixol—Nervous system disorder—Ifosfamide—germ cell cancer	0.00142	0.00271	CcSEcCtD
Zuclopenthixol—Ill-defined disorder—Cisplatin—germ cell cancer	0.00142	0.00271	CcSEcCtD
Zuclopenthixol—Thrombocytopenia—Ifosfamide—germ cell cancer	0.00142	0.00271	CcSEcCtD
Zuclopenthixol—Skin disorder—Ifosfamide—germ cell cancer	0.00141	0.00269	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Ifosfamide—germ cell cancer	0.0014	0.00267	CcSEcCtD
Zuclopenthixol—DRD2—brain—germ cell cancer	0.0014	0.00293	CbGeAlD
Zuclopenthixol—Feeling abnormal—Bleomycin—germ cell cancer	0.0014	0.00267	CcSEcCtD
Zuclopenthixol—Anorexia—Ifosfamide—germ cell cancer	0.00138	0.00263	CcSEcCtD
Zuclopenthixol—Malaise—Cisplatin—germ cell cancer	0.00138	0.00263	CcSEcCtD
Zuclopenthixol—Decreased appetite—Dactinomycin—germ cell cancer	0.00137	0.00262	CcSEcCtD
Zuclopenthixol—Diarrhoea—Vinblastine—germ cell cancer	0.00137	0.00262	CcSEcCtD
Zuclopenthixol—Leukopenia—Cisplatin—germ cell cancer	0.00137	0.00261	CcSEcCtD
Zuclopenthixol—Fatigue—Dactinomycin—germ cell cancer	0.00136	0.0026	CcSEcCtD
Zuclopenthixol—Hypotension—Ifosfamide—germ cell cancer	0.00135	0.00258	CcSEcCtD
Zuclopenthixol—Pain—Dactinomycin—germ cell cancer	0.00135	0.00258	CcSEcCtD
Zuclopenthixol—Body temperature increased—Bleomycin—germ cell cancer	0.00134	0.00256	CcSEcCtD
Zuclopenthixol—ADRA2A—cerebellum—germ cell cancer	0.00133	0.0028	CbGeAlD
Zuclopenthixol—Dizziness—Vinblastine—germ cell cancer	0.00133	0.00253	CcSEcCtD
Zuclopenthixol—Convulsion—Cisplatin—germ cell cancer	0.00133	0.00253	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.00132	0.00252	CcSEcCtD
Zuclopenthixol—Ataxia—Methotrexate—germ cell cancer	0.00131	0.0025	CcSEcCtD
Zuclopenthixol—Myalgia—Cisplatin—germ cell cancer	0.0013	0.00249	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Dactinomycin—germ cell cancer	0.0013	0.00249	CcSEcCtD
Zuclopenthixol—Paraesthesia—Ifosfamide—germ cell cancer	0.0013	0.00248	CcSEcCtD
Zuclopenthixol—Ill-defined disorder—Etoposide—germ cell cancer	0.0013	0.00248	CcSEcCtD
Zuclopenthixol—Anxiety—Cisplatin—germ cell cancer	0.0013	0.00248	CcSEcCtD
Zuclopenthixol—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.00129	0.00247	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.00129	0.00247	CcSEcCtD
Zuclopenthixol—Dyspnoea—Ifosfamide—germ cell cancer	0.00129	0.00246	CcSEcCtD
Zuclopenthixol—HTR2A—endocrine gland—germ cell cancer	0.00129	0.00271	CbGeAlD
Zuclopenthixol—Somnolence—Ifosfamide—germ cell cancer	0.00129	0.00246	CcSEcCtD
Zuclopenthixol—Liver function test abnormal—Methotrexate—germ cell cancer	0.00129	0.00246	CcSEcCtD
Zuclopenthixol—Discomfort—Cisplatin—germ cell cancer	0.00129	0.00246	CcSEcCtD
Zuclopenthixol—Vomiting—Vinblastine—germ cell cancer	0.00128	0.00243	CcSEcCtD
Zuclopenthixol—HTR2A—head—germ cell cancer	0.00127	0.00267	CbGeAlD
Zuclopenthixol—Malaise—Etoposide—germ cell cancer	0.00126	0.00241	CcSEcCtD
Zuclopenthixol—CYP2D6—female gonad—germ cell cancer	0.00126	0.00265	CbGeAlD
Zuclopenthixol—Breast disorder—Methotrexate—germ cell cancer	0.00126	0.0024	CcSEcCtD
Zuclopenthixol—Vertigo—Etoposide—germ cell cancer	0.00126	0.0024	CcSEcCtD
Zuclopenthixol—Decreased appetite—Ifosfamide—germ cell cancer	0.00126	0.0024	CcSEcCtD
Zuclopenthixol—Headache—Vinblastine—germ cell cancer	0.00126	0.0024	CcSEcCtD
Zuclopenthixol—Leukopenia—Etoposide—germ cell cancer	0.00125	0.00239	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.00125	0.00239	CcSEcCtD
Zuclopenthixol—Body temperature increased—Dactinomycin—germ cell cancer	0.00125	0.00238	CcSEcCtD
Zuclopenthixol—Abdominal pain—Dactinomycin—germ cell cancer	0.00125	0.00238	CcSEcCtD
Zuclopenthixol—Fatigue—Ifosfamide—germ cell cancer	0.00125	0.00238	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Cisplatin—germ cell cancer	0.00125	0.00238	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Bleomycin—germ cell cancer	0.00125	0.00238	CcSEcCtD
Zuclopenthixol—Pain—Ifosfamide—germ cell cancer	0.00124	0.00236	CcSEcCtD
Zuclopenthixol—Constipation—Ifosfamide—germ cell cancer	0.00124	0.00236	CcSEcCtD
Zuclopenthixol—Loss of consciousness—Etoposide—germ cell cancer	0.00123	0.00235	CcSEcCtD
Zuclopenthixol—HTR2A—testis—germ cell cancer	0.00123	0.00258	CbGeAlD
Zuclopenthixol—Nervous system disorder—Cisplatin—germ cell cancer	0.00122	0.00234	CcSEcCtD
Zuclopenthixol—Thrombocytopenia—Cisplatin—germ cell cancer	0.00122	0.00233	CcSEcCtD
Zuclopenthixol—Tachycardia—Cisplatin—germ cell cancer	0.00122	0.00233	CcSEcCtD
Zuclopenthixol—Asthenia—Bleomycin—germ cell cancer	0.00122	0.00232	CcSEcCtD
Zuclopenthixol—Convulsion—Etoposide—germ cell cancer	0.00121	0.00232	CcSEcCtD
Zuclopenthixol—Skin disorder—Cisplatin—germ cell cancer	0.00121	0.00231	CcSEcCtD
Zuclopenthixol—Hypertension—Etoposide—germ cell cancer	0.00121	0.00231	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Cisplatin—germ cell cancer	0.00121	0.0023	CcSEcCtD
Zuclopenthixol—Pruritus—Bleomycin—germ cell cancer	0.0012	0.00229	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Ifosfamide—germ cell cancer	0.00119	0.00228	CcSEcCtD
Zuclopenthixol—Eosinophilia—Methotrexate—germ cell cancer	0.00119	0.00228	CcSEcCtD
Zuclopenthixol—Nausea—Vinblastine—germ cell cancer	0.00119	0.00227	CcSEcCtD
Zuclopenthixol—Anorexia—Cisplatin—germ cell cancer	0.00119	0.00227	CcSEcCtD
Zuclopenthixol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.00118	0.00226	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.00118	0.00226	CcSEcCtD
Zuclopenthixol—Discomfort—Etoposide—germ cell cancer	0.00118	0.00225	CcSEcCtD
Zuclopenthixol—CYP2D6—endocrine gland—germ cell cancer	0.00117	0.00246	CbGeAlD
Zuclopenthixol—Hypotension—Cisplatin—germ cell cancer	0.00117	0.00223	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Dactinomycin—germ cell cancer	0.00116	0.00222	CcSEcCtD
Zuclopenthixol—CYP2D6—head—germ cell cancer	0.00116	0.00243	CbGeAlD
Zuclopenthixol—Body temperature increased—Ifosfamide—germ cell cancer	0.00114	0.00219	CcSEcCtD
Zuclopenthixol—Abdominal pain—Ifosfamide—germ cell cancer	0.00114	0.00219	CcSEcCtD
Zuclopenthixol—Pancytopenia—Methotrexate—germ cell cancer	0.00114	0.00218	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Etoposide—germ cell cancer	0.00114	0.00218	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.00114	0.00217	CcSEcCtD
Zuclopenthixol—HTR2A—cerebellum—germ cell cancer	0.00113	0.00238	CbGeAlD
Zuclopenthixol—Asthenia—Dactinomycin—germ cell cancer	0.00113	0.00216	CcSEcCtD
Zuclopenthixol—Dysuria—Methotrexate—germ cell cancer	0.00113	0.00215	CcSEcCtD
Zuclopenthixol—Neutropenia—Methotrexate—germ cell cancer	0.00113	0.00215	CcSEcCtD
Zuclopenthixol—Paraesthesia—Cisplatin—germ cell cancer	0.00112	0.00214	CcSEcCtD
Zuclopenthixol—Thrombocytopenia—Etoposide—germ cell cancer	0.00112	0.00214	CcSEcCtD
Zuclopenthixol—CYP2D6—testis—germ cell cancer	0.00112	0.00235	CbGeAlD
Zuclopenthixol—Tachycardia—Etoposide—germ cell cancer	0.00112	0.00213	CcSEcCtD
Zuclopenthixol—Dyspnoea—Cisplatin—germ cell cancer	0.00111	0.00212	CcSEcCtD
Zuclopenthixol—Skin disorder—Etoposide—germ cell cancer	0.00111	0.00212	CcSEcCtD
Zuclopenthixol—Erectile dysfunction—Methotrexate—germ cell cancer	0.00111	0.00212	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Etoposide—germ cell cancer	0.00111	0.00211	CcSEcCtD
Zuclopenthixol—HRH1—brain—germ cell cancer	0.0011	0.00232	CbGeAlD
Zuclopenthixol—Photosensitivity reaction—Methotrexate—germ cell cancer	0.0011	0.0021	CcSEcCtD
Zuclopenthixol—Anorexia—Etoposide—germ cell cancer	0.00109	0.00208	CcSEcCtD
Zuclopenthixol—Decreased appetite—Cisplatin—germ cell cancer	0.00108	0.00207	CcSEcCtD
Zuclopenthixol—ADRA2A—brain—germ cell cancer	0.00108	0.00228	CbGeAlD
Zuclopenthixol—Diarrhoea—Dactinomycin—germ cell cancer	0.00108	0.00206	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.00108	0.00206	CcSEcCtD
Zuclopenthixol—Vomiting—Bleomycin—germ cell cancer	0.00108	0.00206	CcSEcCtD
Zuclopenthixol—Drowsiness—Methotrexate—germ cell cancer	0.00107	0.00205	CcSEcCtD
Zuclopenthixol—Hypotension—Etoposide—germ cell cancer	0.00107	0.00204	CcSEcCtD
Zuclopenthixol—Rash—Bleomycin—germ cell cancer	0.00107	0.00204	CcSEcCtD
Zuclopenthixol—Pain—Cisplatin—germ cell cancer	0.00107	0.00204	CcSEcCtD
Zuclopenthixol—Dermatitis—Bleomycin—germ cell cancer	0.00107	0.00204	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Ifosfamide—germ cell cancer	0.00107	0.00204	CcSEcCtD
Zuclopenthixol—HRH1—lymph node—germ cell cancer	0.00107	0.00224	CbGeAlD
Zuclopenthixol—ADRA2A—lymph node—germ cell cancer	0.00105	0.0022	CbGeAlD
Zuclopenthixol—Asthenia—Ifosfamide—germ cell cancer	0.00104	0.00198	CcSEcCtD
Zuclopenthixol—CYP2D6—cerebellum—germ cell cancer	0.00103	0.00217	CbGeAlD
Zuclopenthixol—Sweating—Methotrexate—germ cell cancer	0.00103	0.00197	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Cisplatin—germ cell cancer	0.00103	0.00196	CcSEcCtD
Zuclopenthixol—Paraesthesia—Etoposide—germ cell cancer	0.00103	0.00196	CcSEcCtD
Zuclopenthixol—Pruritus—Ifosfamide—germ cell cancer	0.00102	0.00196	CcSEcCtD
Zuclopenthixol—Dyspnoea—Etoposide—germ cell cancer	0.00102	0.00195	CcSEcCtD
Zuclopenthixol—Somnolence—Etoposide—germ cell cancer	0.00102	0.00194	CcSEcCtD
Zuclopenthixol—Hepatobiliary disease—Methotrexate—germ cell cancer	0.00102	0.00194	CcSEcCtD
Zuclopenthixol—Nausea—Bleomycin—germ cell cancer	0.00101	0.00192	CcSEcCtD
Zuclopenthixol—Vomiting—Dactinomycin—germ cell cancer	0.001	0.00192	CcSEcCtD
Zuclopenthixol—Agranulocytosis—Methotrexate—germ cell cancer	0.001	0.00191	CcSEcCtD
Zuclopenthixol—Rash—Dactinomycin—germ cell cancer	0.000996	0.0019	CcSEcCtD
Zuclopenthixol—Decreased appetite—Etoposide—germ cell cancer	0.000994	0.0019	CcSEcCtD
Zuclopenthixol—Diarrhoea—Ifosfamide—germ cell cancer	0.000991	0.00189	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Etoposide—germ cell cancer	0.000987	0.00188	CcSEcCtD
Zuclopenthixol—Body temperature increased—Cisplatin—germ cell cancer	0.000987	0.00188	CcSEcCtD
Zuclopenthixol—Fatigue—Etoposide—germ cell cancer	0.000986	0.00188	CcSEcCtD
Zuclopenthixol—Constipation—Etoposide—germ cell cancer	0.000978	0.00187	CcSEcCtD
Zuclopenthixol—Pain—Etoposide—germ cell cancer	0.000978	0.00187	CcSEcCtD
Zuclopenthixol—Dizziness—Ifosfamide—germ cell cancer	0.000957	0.00183	CcSEcCtD
Zuclopenthixol—Urinary tract disorder—Methotrexate—germ cell cancer	0.000952	0.00182	CcSEcCtD
Zuclopenthixol—Urethral disorder—Methotrexate—germ cell cancer	0.000945	0.0018	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Etoposide—germ cell cancer	0.000942	0.0018	CcSEcCtD
Zuclopenthixol—Nausea—Dactinomycin—germ cell cancer	0.000938	0.00179	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Etoposide—germ cell cancer	0.000935	0.00179	CcSEcCtD
Zuclopenthixol—Visual impairment—Methotrexate—germ cell cancer	0.000929	0.00177	CcSEcCtD
Zuclopenthixol—HTR2A—brain—germ cell cancer	0.000922	0.00194	CbGeAlD
Zuclopenthixol—Vomiting—Ifosfamide—germ cell cancer	0.00092	0.00176	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Cisplatin—germ cell cancer	0.00092	0.00176	CcSEcCtD
Zuclopenthixol—Rash—Ifosfamide—germ cell cancer	0.000913	0.00174	CcSEcCtD
Zuclopenthixol—Dermatitis—Ifosfamide—germ cell cancer	0.000912	0.00174	CcSEcCtD
Zuclopenthixol—Abdominal pain—Etoposide—germ cell cancer	0.000904	0.00173	CcSEcCtD
Zuclopenthixol—Body temperature increased—Etoposide—germ cell cancer	0.000904	0.00173	CcSEcCtD
Zuclopenthixol—Eye disorder—Methotrexate—germ cell cancer	0.000901	0.00172	CcSEcCtD
Zuclopenthixol—Tinnitus—Methotrexate—germ cell cancer	0.000899	0.00172	CcSEcCtD
Zuclopenthixol—Asthenia—Cisplatin—germ cell cancer	0.000895	0.00171	CcSEcCtD
Zuclopenthixol—Cardiac disorder—Methotrexate—germ cell cancer	0.000895	0.00171	CcSEcCtD
Zuclopenthixol—Angiopathy—Methotrexate—germ cell cancer	0.000875	0.00167	CcSEcCtD
Zuclopenthixol—Immune system disorder—Methotrexate—germ cell cancer	0.000871	0.00166	CcSEcCtD
Zuclopenthixol—Nausea—Ifosfamide—germ cell cancer	0.00086	0.00164	CcSEcCtD
Zuclopenthixol—Diarrhoea—Cisplatin—germ cell cancer	0.000854	0.00163	CcSEcCtD
Zuclopenthixol—Mental disorder—Methotrexate—germ cell cancer	0.000845	0.00161	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Etoposide—germ cell cancer	0.000842	0.00161	CcSEcCtD
Zuclopenthixol—CYP2D6—brain—germ cell cancer	0.00084	0.00176	CbGeAlD
Zuclopenthixol—Erythema—Methotrexate—germ cell cancer	0.000839	0.0016	CcSEcCtD
Zuclopenthixol—Malnutrition—Methotrexate—germ cell cancer	0.000839	0.0016	CcSEcCtD
Zuclopenthixol—Asthenia—Etoposide—germ cell cancer	0.00082	0.00157	CcSEcCtD
Zuclopenthixol—Pruritus—Etoposide—germ cell cancer	0.000809	0.00154	CcSEcCtD
Zuclopenthixol—Vomiting—Cisplatin—germ cell cancer	0.000794	0.00152	CcSEcCtD
Zuclopenthixol—Vision blurred—Methotrexate—germ cell cancer	0.000791	0.00151	CcSEcCtD
Zuclopenthixol—Rash—Cisplatin—germ cell cancer	0.000787	0.0015	CcSEcCtD
Zuclopenthixol—Dermatitis—Cisplatin—germ cell cancer	0.000786	0.0015	CcSEcCtD
Zuclopenthixol—Diarrhoea—Etoposide—germ cell cancer	0.000782	0.00149	CcSEcCtD
Zuclopenthixol—Ill-defined disorder—Methotrexate—germ cell cancer	0.000779	0.00149	CcSEcCtD
Zuclopenthixol—Malaise—Methotrexate—germ cell cancer	0.000757	0.00144	CcSEcCtD
Zuclopenthixol—Dizziness—Etoposide—germ cell cancer	0.000756	0.00144	CcSEcCtD
Zuclopenthixol—Vertigo—Methotrexate—germ cell cancer	0.000754	0.00144	CcSEcCtD
Zuclopenthixol—Leukopenia—Methotrexate—germ cell cancer	0.000751	0.00143	CcSEcCtD
Zuclopenthixol—Nausea—Cisplatin—germ cell cancer	0.000741	0.00142	CcSEcCtD
Zuclopenthixol—Convulsion—Methotrexate—germ cell cancer	0.000727	0.00139	CcSEcCtD
Zuclopenthixol—Vomiting—Etoposide—germ cell cancer	0.000727	0.00139	CcSEcCtD
Zuclopenthixol—Rash—Etoposide—germ cell cancer	0.000721	0.00138	CcSEcCtD
Zuclopenthixol—Dermatitis—Etoposide—germ cell cancer	0.00072	0.00138	CcSEcCtD
Zuclopenthixol—Headache—Etoposide—germ cell cancer	0.000716	0.00137	CcSEcCtD
Zuclopenthixol—Myalgia—Methotrexate—germ cell cancer	0.000714	0.00136	CcSEcCtD
Zuclopenthixol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.00071	0.00135	CcSEcCtD
Zuclopenthixol—Discomfort—Methotrexate—germ cell cancer	0.000706	0.00135	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Methotrexate—germ cell cancer	0.000685	0.00131	CcSEcCtD
Zuclopenthixol—Nausea—Etoposide—germ cell cancer	0.000679	0.0013	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Methotrexate—germ cell cancer	0.000672	0.00128	CcSEcCtD
Zuclopenthixol—Thrombocytopenia—Methotrexate—germ cell cancer	0.000671	0.00128	CcSEcCtD
Zuclopenthixol—Skin disorder—Methotrexate—germ cell cancer	0.000665	0.00127	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Methotrexate—germ cell cancer	0.000662	0.00126	CcSEcCtD
Zuclopenthixol—Anorexia—Methotrexate—germ cell cancer	0.000653	0.00125	CcSEcCtD
Zuclopenthixol—Hypotension—Methotrexate—germ cell cancer	0.00064	0.00122	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.000624	0.00119	CcSEcCtD
Zuclopenthixol—Insomnia—Methotrexate—germ cell cancer	0.000619	0.00118	CcSEcCtD
Zuclopenthixol—Paraesthesia—Methotrexate—germ cell cancer	0.000615	0.00117	CcSEcCtD
Zuclopenthixol—Dyspnoea—Methotrexate—germ cell cancer	0.000611	0.00117	CcSEcCtD
Zuclopenthixol—Somnolence—Methotrexate—germ cell cancer	0.000609	0.00116	CcSEcCtD
Zuclopenthixol—Dyspepsia—Methotrexate—germ cell cancer	0.000603	0.00115	CcSEcCtD
Zuclopenthixol—Decreased appetite—Methotrexate—germ cell cancer	0.000595	0.00114	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.000591	0.00113	CcSEcCtD
Zuclopenthixol—Fatigue—Methotrexate—germ cell cancer	0.00059	0.00113	CcSEcCtD
Zuclopenthixol—Pain—Methotrexate—germ cell cancer	0.000586	0.00112	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Methotrexate—germ cell cancer	0.000564	0.00108	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Methotrexate—germ cell cancer	0.00056	0.00107	CcSEcCtD
Zuclopenthixol—Body temperature increased—Methotrexate—germ cell cancer	0.000541	0.00103	CcSEcCtD
Zuclopenthixol—Abdominal pain—Methotrexate—germ cell cancer	0.000541	0.00103	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Methotrexate—germ cell cancer	0.000505	0.000963	CcSEcCtD
Zuclopenthixol—Asthenia—Methotrexate—germ cell cancer	0.000491	0.000938	CcSEcCtD
Zuclopenthixol—Pruritus—Methotrexate—germ cell cancer	0.000485	0.000925	CcSEcCtD
Zuclopenthixol—Diarrhoea—Methotrexate—germ cell cancer	0.000469	0.000895	CcSEcCtD
Zuclopenthixol—Dizziness—Methotrexate—germ cell cancer	0.000453	0.000865	CcSEcCtD
Zuclopenthixol—Vomiting—Methotrexate—germ cell cancer	0.000435	0.000831	CcSEcCtD
Zuclopenthixol—Rash—Methotrexate—germ cell cancer	0.000432	0.000825	CcSEcCtD
Zuclopenthixol—Dermatitis—Methotrexate—germ cell cancer	0.000431	0.000824	CcSEcCtD
Zuclopenthixol—Headache—Methotrexate—germ cell cancer	0.000429	0.000819	CcSEcCtD
Zuclopenthixol—Nausea—Methotrexate—germ cell cancer	0.000407	0.000777	CcSEcCtD
